Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03021967
Other study ID # 5581
Secondary ID
Status Completed
Phase N/A
First received January 12, 2017
Last updated May 15, 2017
Start date July 2014
Est. completion date January 2017

Study information

Verified date May 2017
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hospitals, doctors and caregivers, who take care of increasingly heavy patients, are faced with ever more complex situations, particularly in the case of severe, progressive, and incurable pathologies.

Thanks to their willingness and expertise, these care providers try to guarantee the continuity and quality of care for both patients and patients in a palliative situation. Nevertheless, these same actors testify to the complexity they encounter in the care of patients in advanced or terminal stages, especially since the concept of "palliative care", which was often erroneously reduced during the Any end of life and therefore death, remains a source of questions, contradictions, even resistances.

In this context, how do physicians and caregivers appropriate palliative care? How do they react to the complexity and intensity of certain situations? Do they have specific expectations of help or support in the face of certain difficulties? Are there actions to be carried out and developed to make the aid given to these actors of the palliative approach more efficient?

These are the topics that the HUS palliative care service proposes to explore through a study of physicians and caregivers working in HUS services for adult patients with LISP.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Major hospitals, doctors and caregivers, who take care of increasingly heavy patients

Exclusion Criteria:

- Patient under 18 years

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service Soins Palliatifs Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire 3 months